These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
404 related articles for article (PubMed ID: 23665284)
21. Tumor-suppressive microRNA-551b-3p targets H6PD to inhibit gallbladder cancer progression. Ji T; Gao L; Yu Z Cancer Gene Ther; 2021 Jun; 28(6):693-705. PubMed ID: 33250514 [TBL] [Abstract][Full Text] [Related]
22. TGF-β1 facilitates gallbladder carcinoma metastasis by regulating FOXA1 translation efficiency through m Wu Z; Ke Q; Jiang L; Hong H; Pan W; Chen W; Abudukeremu X; She F; Chen Y Cell Death Dis; 2024 Jun; 15(6):422. PubMed ID: 38886389 [TBL] [Abstract][Full Text] [Related]
23. MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer. Xia H; Ooi LL; Hui KM Hepatology; 2013 Aug; 58(2):629-41. PubMed ID: 23471579 [TBL] [Abstract][Full Text] [Related]
24. MicroRNA-182 targets SMAD7 to potentiate TGFβ-induced epithelial-mesenchymal transition and metastasis of cancer cells. Yu J; Lei R; Zhuang X; Li X; Li G; Lev S; Segura MF; Zhang X; Hu G Nat Commun; 2016 Dec; 7():13884. PubMed ID: 27996004 [TBL] [Abstract][Full Text] [Related]
25. LncRNA-HGBC stabilized by HuR promotes gallbladder cancer progression by regulating miR-502-3p/SET/AKT axis. Hu YP; Jin YP; Wu XS; Yang Y; Li YS; Li HF; Xiang SS; Song XL; Jiang L; Zhang YJ; Huang W; Chen SL; Liu FT; Chen C; Zhu Q; Chen HZ; Shao R; Liu YB Mol Cancer; 2019 Nov; 18(1):167. PubMed ID: 31752906 [TBL] [Abstract][Full Text] [Related]
26. Long non-coding RNA PVT1 promotes tumor progression by regulating the miR-143/HK2 axis in gallbladder cancer. Chen J; Yu Y; Li H; Hu Q; Chen X; He Y; Xue C; Ren F; Ren Z; Li J; Liu L; Duan Z; Cui G; Sun R Mol Cancer; 2019 Mar; 18(1):33. PubMed ID: 30825877 [TBL] [Abstract][Full Text] [Related]
27. MiR-424-5p participates in esophageal squamous cell carcinoma invasion and metastasis via SMAD7 pathway mediated EMT. Wang F; Wang J; Yang X; Chen D; Wang L Diagn Pathol; 2016 Sep; 11(1):88. PubMed ID: 27628042 [TBL] [Abstract][Full Text] [Related]
28. MiR-4733-5p promotes gallbladder carcinoma progression via directly targeting kruppel like factor 7. Hu X; Zhang J; Bu J; Yang K; Xu S; Pan M; Xiang D; Chen W Bioengineered; 2022 Apr; 13(4):10691-10706. PubMed ID: 35443866 [TBL] [Abstract][Full Text] [Related]
29. MicroRNA aberrations: An emerging field for gallbladder cancer management. Chandra V; Kim JJ; Mittal B; Rai R World J Gastroenterol; 2016 Feb; 22(5):1787-99. PubMed ID: 26855538 [TBL] [Abstract][Full Text] [Related]
30. Up-regulated microRNA-33b inhibits epithelial-mesenchymal transition in gallbladder cancer through down-regulating CROCC. Xu G; Wei X; Tu Q; Zhou C Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31799620 [TBL] [Abstract][Full Text] [Related]
31. MicroRNA-630 suppresses tumor metastasis through the TGF-β- miR-630-Slug signaling pathway and correlates inversely with poor prognosis in hepatocellular carcinoma. Chen WX; Zhang ZG; Ding ZY; Liang HF; Song J; Tan XL; Wu JJ; Li GZ; Zeng Z; Zhang BX; Chen XP Oncotarget; 2016 Apr; 7(16):22674-86. PubMed ID: 26993767 [TBL] [Abstract][Full Text] [Related]
32. Shikonin suppresses progression and epithelial-mesenchymal transition in hepatocellular carcinoma (HCC) cells by modulating miR-106b/SMAD7/TGF-β signaling pathway. Li X; Zeng X Cell Biol Int; 2020 Feb; 44(2):467-476. PubMed ID: 31617643 [TBL] [Abstract][Full Text] [Related]
33. PLZF inhibits proliferation and metastasis of gallbladder cancer by regulating IFIT2. Shen H; Zhan M; Zhang Y; Huang S; Xu S; Huang X; He M; Yao Y; Man M; Wang J Cell Death Dis; 2018 Jan; 9(2):71. PubMed ID: 29358655 [TBL] [Abstract][Full Text] [Related]
34. PLEK2 promotes gallbladder cancer invasion and metastasis through EGFR/CCL2 pathway. Shen H; He M; Lin R; Zhan M; Xu S; Huang X; Xu C; Chen W; Yao Y; Mohan M; Wang J J Exp Clin Cancer Res; 2019 Jun; 38(1):247. PubMed ID: 31182136 [TBL] [Abstract][Full Text] [Related]
35. Downregulation of miR-3127-5p promotes epithelial-mesenchymal transition via FZD4 regulation of Wnt/β-catenin signaling in non-small-cell lung cancer. Yang Y; Sun Y; Wu Y; Tang D; Ding X; Xu W; Su B; Gao W Mol Carcinog; 2018 Jul; 57(7):842-853. PubMed ID: 29566281 [TBL] [Abstract][Full Text] [Related]
36. Chemokine (C-X-C motif) ligand 12 is associated with gallbladder carcinoma progression and is a novel independent poor prognostic factor. Lee HJ; Lee K; Lee DG; Bae KH; Kim JS; Liang ZL; Huang SM; Suk Oh Y; Kim HY; Jo DY; Min JK; Kim JM; Lee HJ Clin Cancer Res; 2012 Jun; 18(12):3270-80. PubMed ID: 22553346 [TBL] [Abstract][Full Text] [Related]
37. Prohibitin overexpression predicts poor prognosis and promotes cell proliferation and invasion through ERK pathway activation in gallbladder cancer. Cao Y; Liang H; Zhang F; Luan Z; Zhao S; Wang XA; Liu S; Bao R; Shu Y; Ma Q; Zhu J; Liu Y J Exp Clin Cancer Res; 2016 Apr; 35():68. PubMed ID: 27084680 [TBL] [Abstract][Full Text] [Related]
38. Transforming growth factor-β and epithelial-mesenchymal transition are associated with pulmonary metastasis in adenoid cystic carcinoma. Dong L; Ge XY; Wang YX; Yang LQ; Li SL; Yu GY; Gao Y; Fu J Oral Oncol; 2013 Nov; 49(11):1051-8. PubMed ID: 23962790 [TBL] [Abstract][Full Text] [Related]
39. SPOCK1 as a potential cancer prognostic marker promotes the proliferation and metastasis of gallbladder cancer cells by activating the PI3K/AKT pathway. Shu YJ; Weng H; Ye YY; Hu YP; Bao RF; Cao Y; Wang XA; Zhang F; Xiang SS; Li HF; Wu XS; Li ML; Jiang L; Lu W; Han BS; Jie ZG; Liu YB Mol Cancer; 2015 Jan; 14(1):12. PubMed ID: 25623055 [TBL] [Abstract][Full Text] [Related]
40. Roles of Pin1 as a Key Molecule for EMT Induction by Activation of STAT3 and NF-κB in Human Gallbladder Cancer. Nakada S; Kuboki S; Nojima H; Yoshitomi H; Furukawa K; Takayashiki T; Takano S; Miyazaki M; Ohtsuka M Ann Surg Oncol; 2019 Mar; 26(3):907-917. PubMed ID: 30610554 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]